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Summary
Branching morphogenesis is a key process in the for-
mation of vascular networks. To date, little is known
regarding the molecular events regulating this pro-
cess. We investigated the involvement of synectin in
this process. In zebrafish embryos, synectin knock-
down resulted in a hypoplastic dorsal aorta and hypo-
branched, stunted, and thin intersomitic vessels due
to impaired migration and proliferation of angioblasts
and arterial endothelial cells while not affecting ve-
nous development. Synectin2/2 mice demonstrated
decreased body and organ size, reduced numbers of
arteries, and an altered pattern of arterial branching
in multiple vascular beds while the venous system re-
mained normal. Murine synectin2/2 primary arterial,
but not venous, endothelial cells showed decreased
in vitro tube formation, migration, and proliferation
and impaired polarization due to abnormal localization
of activated Rac1. We conclude that synectin is in-
volved in selective regulation of arterial, but not ve-
nous, growth and branching morphogenesis and that
Rac1 plays an important role in this process.
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The growth of arterial networks during development as
well as postnatally is an important and poorly under-
stood biological process. Developmental arteriogenesis
proceeds via branching of the newly formed vasculature
while arteriogenesis in adult tissues is thought to occur
by enlargement of preexisting arteries or de novo arterial
branching and growth (Carmeliet, 2003; Simons, 2005).
To date, few molecular details of arterial branching
have been established.
We have recently identified a receptor scaffold pro-
tein, synectin (GIPC1), based on its ability to bind the cy-
toplasmic domain of FGF receptor syndecan-4, a trans-
membrane proteoglycan involved in various processes
of cellular and molecular recognition, signaling, and an-
giogenesis (Gao et al., 2000). Synectin is a single PDZ
domain protein that has been reported to interact with
more than 20 binding partners, including GTPase-acti-
vating protein RGS-GAIP (De Vries et al., 1998), trans-
membrane protein M-SemF (Wang et al., 1999), receptor
tyrosine kinases TrkA and TrkB (Kato et al., 2004; Lou
et al., 2001), integrin a 6A subunit (El Mourabit et al.,
2002), and neuropilin-1 (Cai and Reed, 1999).
The ability of synectin to interact with various proteins
involved in angiogenic signaling suggests that it may
play a prominent role as an adaptor that links multiple
growth factor-supported recognition processes to intra-
cellular signal transduction, control, and effector sys-
tems in the vasculature (Tkachenko et al., 2005). The
present study was undertaken, therefore, to elucidate
the role of synectin in vascular development and adult
angiogenesis. To this end, we studied mice homozy-
gous for the synectin gene disruption and zebrafish fol-
lowing knockdown of synectin expression. In both
cases, we have observed extensive impairment of arte-
rial, but not venous, development. These data implicate
synectin as an important selective regulator of arterial
vascular growth.
Results
Expression of Synectin in Zebrafish Embryos
To elucidate the function of synectin, we first studied its
expression pattern in zebrafish embryos at different
stages of development. Whole-mount in situ hybridiza-
tion, using the zebrafish synectin (z-synectin) antisense
riboprobe, revealed that from the 15 somite stage on-
ward, synectin is widely expressed in different tissues
including the brain, neural tube, somites, and both arte-
rial and venous blood vessels (Figure 1A). RT-PCR anal-
ysis of flow cytometry-isolated GFP+ cells from 16 and
24 hr postfertilization (hpf) Tg(fli1:EGFP)y1 (Lawson and
Weinstein, 2002) zebrafish embryos revealed that these
GFP+ cells expressed synectin (see Figure S1 in the
Supplemental Data available with this article online).
This expression pattern was specific, as the cells also
expressed robo4, another gene expressed in endothelial
cells (Bedell et al., 2005; Huminiecki et al., 2002), but not
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784Figure 1. Synectin Knockdown Impairs Arte-
rial Development in Zebrafish
(A) Transverse section through the rostral
trunk of a 28 hpf control embryo, stained by
whole-mount in situ hybridization for the anti-
sense z-synectin riboprobe, revealing ex-
pression of synectin in the neural tube (NT),
somites (S), dorsal aorta (black arrow), and
posterior cardinal vein (white arrow). No sig-
nal was detected when the z-synectin sense
probe was used (not shown). The dorsal
side of the embryo is at the top of the figure.
The scale bar represents 10 mm.
(B and C) Dorsal view of early stage (16.5 hpf)
Tg(fli1:EGFP)y1 zebrafish embryos, revealing
migration of GFP+ angioblasts from the lat-
eral plate mesoderm to the midline. (B) In
control embryos, migration of these angio-
blasts to the midline occurred in an orderly
and stereotyped anteroposterior zipper-like
pattern. Once at the midline, these angio-
blasts coalesced to form the large axial ves-
sels. (C) In contrast, in synectinKD embryos,
some angioblasts stalled at the lateral plate
mesoderm or at intermediate locations on
their latero-medial trajectory (arrowheads),
while other angioblasts migrated more slowly
and in more irregular and wider streaks (prob-
ably as a result of their migration defect). As
a result, coalescence of these angioblasts
into the axial vascular cords is delayed. The
head of the embryo is at the top of the figures.
The scale bar represents 50 mm.
(D and E) Lateral view of the trunk of 28 hpf control (D) and synectinKD (E) embryos, stained by whole-mount in situ hybridization for the arterial
ephrinB2a marker, revealing a reduced staining of the dorsal aorta (arrowhead) in synectinKD embryos (E) as compared to control embryos (D).
The scale bar represents 50 mm. Anterior side of the embryos is left; dorsal side is at the top of the figure.
(F and G) Lateral view of the trunk of 28 hpf control (F) and synectinKD (G) embryos, stained by whole-mount in situ hybridization for the venous flt4
marker, revealing comparable staining of the posterior cardinal vein (arrowhead) in synectinKD embryos (F) and control embryos (G). The scale
bar represents 50 mm. Anterior side of the embryos is left; dorsal side is at the top of the figure.
(H and I) Transverse sections through the trunk of 28 hpf control (H) and synectinKD (I) Tg(fli1:EGFP)y1 embryos, immunostained for GFP (GFP is
green and the nuclear counterstain DAPI is blue). The dorsal aorta (white arrow) has a smaller lumen in synectinKD than control embryos; the size
of the posterior cardinal vein (white arrowhead) is comparable in both genotypes. Angioblasts, stalling midway through their latero-medial tra-
jectory, were only detected in synectinKD embryos at this stage (I, red arrow). Higher magnification of the axial vessels is shown in the lower part
of (H) and (I). The dorsal side of the embryo faces upward. The scale bars represent 10 mm in the upper part and 20 mm in the lower part of (H)
and (I).islet-2, a selective marker of neuronal cell subtypes
(Lewis and Eisen, 2003) (Figure S1).
Knockdown of Synectin in Zebrafish
We then knocked down synectin protein levels in zebra-
fish embryos by injecting in one-cell stage embryos the
antisense morpholino oligonucleotide MO-ATG-1. In
a chimeric z-synectin/luciferase fusion reporter assay
(Ny et al., 2005), MO-ATG-1 dose-dependently sup-
pressed translation of this reporter in vitro (Figure S2A).
At the maximally tolerated dose (16 ng per embryo), MO-
ATG-1 lowered synectin protein levels by more than
90% in 24 hpf synectin knockdown (synectinKD) zebra-
fish embryos (Figure S2B). MO-ATG-1 dose-depen-
dently induced specific vascular defects, described in
detail below (see also Table S1). A 5 base pair mismatch
control morpholino (MO-ATG-ctr) was ineffective in the
luciferase reporter assay and lowered synectin protein
levels only by 28%, even after injection of 24 ng/embryo
(Figure S2). This minor reduction of synectin levels was
insufficient to induce any of the specific vascular defects
(see below; see Table S2).Macroscopic inspection revealed that synectinKD em-
bryos had a normal size and shape, swam normally,
and appeared healthy during the first 2 days postfertiliza-
tion (dpf). Apart from a slightly smaller head (possibly
suggesting a neuronal phenotype), they did not exhibit
any other macroscopically visible overt deformities or
malformations. In situ hybridization of whole-mount em-
bryos using probes specific for the developing heart
(cmlc2; Figure S3) or somites (myoD; data not shown) re-
vealed that these organs developed normally in synec-
tinKD embryos. Microscopic inspection of live embryos
revealed that blood flow in the large axial vessels and
intersomitic vessels (ISVs) was sluggish or even absent
in most 48 hpf synectinKD embryos. Also, beyond 2 dpf,
morphantembryos started to develop pericardial edema,
moved less actively, and ultimately died around 3–4 dpf.
Selective Arterial Defects in SynectinKD Zebrafish
To visualize vessel defects in more detail, we analyzed
Tg(fli1:EGFP)y1 zebrafish from the earliest stage of ves-
sel development (Lawson and Weinstein, 2002). At 16
hpf (15 somite stage), angioblasts in control embryos
Regulation of Arterial Branching Morphogenesis
785Figure 2. Synectin Knockdown Impairs ISV Formation
(A and B) In control embryos, the ISVs branched at designated sites, navigated dorsally to the dorsal roof, and formed a DLAV by 40 hpf (A); at
each branch site, an ISV formed at the left and right side of the trunk. In synectinKD embryos (B), the ISVs had an irregular shape, consisted of
slender endothelial cells (arrowhead), stalled halfway through their dorsal trajectory (asterisks), and failed to form a DLAV. In some cases, the
ISVs entirely failed to branch off from the aorta (at the arrow, only a single ISV at the right side of the trunk is present). The white dotted line in-
dicates the level where the DLAV normally should form. The head of the embryo faces left in the figures. The scale bars represent 50 mm.
(C–D) In vivo proliferation assay. Transverse sections through 30 hpf control (C) and synectinKD (D) embryos stained for BrDU (red) and GFP
(green), revealing double-stained yellow BrDU+/GFP+ cells upon merging of both figures (arrowheads). The scale bars represent 10 mm.
(E) Counting of BrDU+/GFP+ endothelial cells revealed that arterial endothelial cell proliferation was significantly reduced in synectinKD embryos
(white bars) as compared to control embryos (blue bars), while venous endothelial cell proliferation was unaffected. Error bars represent the
SEM.
(F) Injection of m-synectin mRNA (rose bars) partially rescued the synectin knockdown phenotype (gray bars). The vascular defects (thin aorta
and absence of ISV sprouting) were rescued inw40% of synectinKD embryos.migrated from the lateral plate mesoderm to the midline,
where they coalesced into a vascular cord (Figure 1B).
These endothelial clusters subsequently acquired a lu-
men and enlarged, thereby establishing a patent dorsal
aorta and posterior cardinal vein. Consistent with previ-
ous findings (Fouquet et al., 1997; Jin et al., 2005), angio-
blast migration to the midline occurred in an orderly, ste-
reotyped zipper-like pattern, progressing from the
anterior to the posterior trunk (Figure 1B).
In synectinKD embryos, endothelial progenitors ini-
tially started to migrate normally at 14 hpf. However,
subsequent migration of these angioblasts to the mid-
line was impaired in 36% of the synectinKD embryos (Ta-
ble S2), with a fraction of angioblasts stalling at the lat-
eral plate mesoderm or at intermediate locations on
their latero-medial trajectory to the midline (Figure 1C).
Other angioblasts appeared to migrate more irregularly
and in wider, more disorganized streaks, as evidenced
by the abnormal zipper-like pattern of angioblast migra-
tion (Figure 1C). As a result, formation of the dorsal aorta
was delayed and impaired, resulting in a much smaller
lumen and thin cord-like appearance of this axial artery,
in 61% of synectinKD embryos (Table S2). Surprisingly,
knockdown of synectin did not at all affect the formation
of the posterior cardinal vein (Table S2).
Whole-mount in situ hybridization for the arterial-spe-
cific marker ephrinB2a confirmed that the dorsal aorta
was thin and underdeveloped, while formation of theflt4-positive posterior cardinal vein was normal (Figures
1D–1G). To further prove that loss of synectin impaired
the formation of the dorsal aorta, synectinKD
Tg(fli1:EGFP)y1 embryos were immunostained with an
anti-GFP antibody and transverse sections were coun-
terstained with the nuclear stain DAPI. As shown in Fig-
ures 1H and 1I, the lumen of the dorsal aorta was abnor-
mally small, while the posterior cardinal vein was
unaffected in synectinKD embryos. Interestingly, in syn-
ectinKD embryos, endothelial progenitors were often still
detectable in the lateral plate mesoderm or at intermedi-
ate locations on their latero-medial trajectory to the mid-
line, at a stage when these cells already had reached the
midline in control embryos (Figure 1I). Thus, knockdown
of synectin impaired the development of the large arte-
rial, but not venous, axial vessel.
Branching Defects of Intersomitic Vessels
in SynectinKD Zebrafish
Once the dorsal aorta was formed, intersomitic vessels
(ISVs) branched off at designated branch sites into the
intersomitic boundaries by 20 hpf in control embryos.
ISVs navigated to the dorsolateral roof of the neural
tube with the most dorsally positioned endothelial tip
cell splitting into the anterior and posterior direction to
establish, by 48 hpf, the dorsal longitudinal anastamotic
vessel (DLAV) via fusion with adjacent endothelial cells
(Figure 2A). In synectinKD embryos, sprouting of ISVs
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some primary ISVs at their designated branch sites
failed to occur at all (Figure 2B). When counting the em-
bryos in which at least five ISVs failed to branch, <1% of
control embryos but up to 71% of synectinKD embryos
were affected (Table S2). Furthermore, ISVs were thin-
ner, frequently consisting of slender endothelial cell ex-
tensions (Figure 2B). In 82% of 40 hpf synectinKD em-
bryos, most ISVs stalled halfway through their normal
dorsal trajectory, arresting at the level of the floor plate
of the neural tube and thus never forming a continuous
DLAV (Figure 2B; Table S2). The ISVs of 40 hpf synec-
tinKD embryos contained fewer endothelial cells than
control embryos (1.966 0.07 cells/ISV in synectinKD em-
bryos versus 3.006 0.07 in control embryos; n = 10 em-
bryos; p < 0.005). Red blood cells could not be detected
in these stunted and slender ISVs upon live screening,
suggesting defects of lumenization as well.
Selective Arterial Endothelial Cell Defects
in SynectinKD Zebrafish
Angioblasts in the lateral plate mesoderm give rise se-
lectively to either the dorsal aorta or the posterior cardi-
nal vein, but not to both (Zhong et al., 2001), while ISVs
form via emigration of nonproliferating arterial endothe-
lial cells from the dorsal aorta (Childs et al., 2002). Thus,
our findings that a fraction of angioblasts stalled in the
lateral plate mesoderm and that endothelial cells stalled
halfway through their dorsal ISV trajectory in synectinKD
embryos suggest that synectin knockdown impaired the
migration of arterial endothelial (progenitor) cells with-
out affecting the venous endothelial cell lineage.
Interestingly, angioblast migration defects occurred
less frequently than aorta hypoplasia (36% versus
61%) in synectinKD embryos (Table S2), raising the
question as to whether or not only migration, but per-
haps also proliferation, of arterial endothelial cells
might be impaired by synectin knockdown. To verify
this hypothesis, we incubated Tg(fli1:EGFP)y1 zebrafish
embryos with BrdU at 20 hpf (i.e., when the aorta is en-
larging and ISVs start sprouting) and counted the
BrdU+GFP+ endothelial cells in arteries (dorsal aorta
and ISVs) or veins (posterior cardinal vein) at 30 hpf,
when ISV formation was completed (Figures 2C and
2D). Significantly fewer arterial endothelial cells were
found to proliferate in synectinKD than control embryos
(0.29 6 0.15 cells/section in synectinKD embryos versus
1.30 6 0.10 cells/section in control embryos; n = 11;
p < 0.005). In contrast, a comparable number of endothe-
lial cells were proliferating in the posterior cardinal vein
in either genotype (0.80 6 0.10 cells/section in synec-
tinKD embryos versus 0.80 6 0.03 cells/section in con-
trol embryos; n = 11; p = 1.00; Figure 2E). Overall, these
results indicate that the arterial defects in synectinKD
embryos are likely due to an impairment of both prolif-
eration and migration of the arterial endothelial cell
lineage.
Specificity of the SynectinKD Phenotype
To demonstrate the specificity of arterial defects in syn-
ectinKD embryos, we used another morpholino, MO-
ATG-2, designed to bind a distinct sequence in the 50-
UTR synectin mRNA. MO-ATG-2 dose-dependently
inhibited the translation of the z-synectin/luciferasereporter in vitro (Figure S2A). In addition, injection of 8
ng MO-ATG-2 per embryo suppressed synectin protein
levels by 90% in 24 hpf zebrafish embryos in vivo
(Figure S2B). Qualitatively and quantitatively, MO-ATG-
2 caused vascular defects indistinguishable from those
induced by MO-ATG-1 (Figure S4; Table S2).
We also attempted to rescue vascular development
via coinjection of MO-ATG-1 and synectin mRNA in
one-cell stage embryos using the murine synectin (m-
synectin) mRNA, as the zebrafish-specific MO-ATG-1
morpholino was unable to bind the murine sequence be-
cause of an 8 base pair mismatch (Figure S5A). Injection
of 350 pg m-synectin mRNA per embryo resulted in
a transient expression of m-synectin protein during the
first 24 hpf (Figure S5B). When expressed as percentage
of the endogenous z-synectin protein levels, m-synectin
levels were 52%, 73%, and only 16% at 6, 12, and 24 hpf,
respectively (Figure S5B). Higher expression of m-syn-
ectin could not be achieved, as larger amounts of
m-synectin mRNA were toxic for early embryo develop-
ment (data not shown). Nonetheless, coinjection of
m-synectin mRNA and MO-ATG-1 partially rescued the
underdevelopment of the dorsal aorta and the hypo-
branching of the ISVs in approximately 40% of the syn-
ectinKD embryos (Figure 2F). This partial rescue of the
vascular defects further underscores the specificity of
the knockdown vascular phenotype.
Generation of Synectin-Deficient Mice
To extend these findings, we further investigated the
loss of synectin expression in mice. The disruption of
the synectin gene using a gene trap (Zambrowicz
et al., 1998) fully eliminated its expression in all major
organ tissues (Figure 3A) including both cardiac
smooth muscle cells and primary microvascular endo-
thelial cells. Synectin2/2 mice appeared grossly normal
although smaller than their heterozygous or wild-type
littermates (Table 1). In 15 litters of synectin hetero-
zygous crosses, synectin2/2 mice accounted for 29%
of live births, suggesting the absence of embryonic
lethality.
Selective Arterial Defects in Synectin2/2 Mice
Histology demonstrated reduced arteriole counts in the
myocardium and a lower vessel density per unit tissue
volume and area (Table 1) with statistically significant
reductions in VE-cadherin (endothelial cell mass; 1.45-
fold, p < 0.01) and a smooth muscle actin (smooth mus-
cle cell mass; 1.85-fold, p < 0.01) mRNA levels. Quantita-
tive PCR analysis further showed a 3.55 6 0.40 fold
increase in HIF-1a and a 2.76 6 0.17 fold increase in
VEGF-A mRNA expression in the myocardium of synec-
tin2/2 compared to synectin+/+ mice (p < 0.01 for both),
suggesting that the reduction in arterial circulation re-
sulted in tissue ischemia.
Coronary and microcomputed tomography (micro-
CT) angiograms of the cardiac and renal vasculature of
synectin2/2mice demonstrated a reduction in size of ar-
terial trees and a significant reduction in both arterial
branching and density in both organs (Figures 3B and
3C) with a decrease in fractal dimension (Df) (Table 1).
Thus, synectin gene disruption affected not only the
vascular density but the branching pattern as well.
This was confirmed by a-actin staining of arterioles in
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(A) RT-PCR and Western blot analysis of synectin knockout and wild-type organ tissue from 6- to 10-week-old male mice. Analyses indicate dis-
ruption of both synectin gene expression and protein production. SK Mu = skeletal muscle.
(B) FITC-dextran-perfused coronary angiograms (top, 23), anti-a smooth muscle actin staining of cardiac arterioles (middle), and reconstructed
micro-CT images of the left anterior descending arteries (top, 8 mm resolution).
(C) Reconstructed micro-CT images of whole kidneys (16 mm resolution; n = 3) in age- and gender-matched mice. Note marked reduction in
branching in synectin2/2 mice (*p < 0.05 versus control mice).
(D) Quantitative analysis of micro-CT images indicates a marked decrease in total number of <100 mm diameter vessels. This observation is con-
sistent with the anti-a smooth muscle actin staining analysis. Means 6 SEM, p% 0.05.
(E) Western blots of myocardial tissues of synectin2/2 and synectin+/+ mice. Note reduced expression of the arterial markers ephrin B2 while the
expression of the venous EphB4 marker is unchanged.the myocardium of synectin2/2 and synectin+/+ mice
and by visual inspection of 3D-reconstructed coronary
angiograms (Figure 3B). Micro-CT analysis of renal vas-
culature produced similar results (Figure 3C). Analysis of
peripheral limb circulation likewise demonstrated both
reduced vessel diameter and branching of small arteri-
oles in synectin2/2 mice (data not shown).
Quantitative analysis of both coronary and renal mi-
cro-CT images demonstrated that the most dramatic re-
duction in branching was among arteries under the 100
mm diameter range that accounted for about 50% of all
arterial blood vessels (Figure 3D). Western blotting of
myocardial tissues demonstrated a significant reduction
in expression of the arterial marker ephrin B2, but not the
venous marker EphB4, suggesting that the reduction in
vascularity was limited to the arterial and not the venous
system (Figure 3E). Peripheral and renal vein angio-
grams demonstrated no gross differences between syn-
ectin2/2 and synectin+/+ mice (data not shown). Thus,
these results are in agreement with the zebrafish datathat likewise demonstrate an arterial, but not venous,
formation defect.
Impaired Cardiac Performance in Synectin2/2 Mice
We next examined the functional impact of the global
synectin knockout on cardiac function. Systolic dys-
function in synectin2/2 mice was documented by a sig-
nificant reduction in the left ventricular (LV) fractional
shortening, ejection fraction, and stroke volume demon-
strated by 2D echocardiography (Table 1). Pressure vol-
ume loop analysis (Figures 4A and 4B) confirmed the re-
duction in LV contractility by demonstrating decreased
systolic blood pressure generation and altered end-sys-
tolic pressure volume relationship.
Abnormal measures of diastolic function in synectin2/2
animals included an increase in the left ventricular stiff-
ness derived from pressure volume loop studies (tau
and2dP/dt; see Table 1) as well as altered end-diastolic
pressure volume relationship (Figure 4B). Interestingly,
the reduction in cardiac arterial mass did not affect
Developmental Cell
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Hearts
Synectin2/2 Synectin+/+ p Value
Body weight (g) 16.7 6 1.3 19.9 6 0.5 0.03
Heart weight (g) 0.07 6 0.001 0.11 6 0.001 <0.01
Heart/body weight
ratio (%)
0.41 6 0.05 0.55 6 0.02 0.03
Cardiac output (ml/min) 6397 6 182 9143 6 309 <0.01
Stroke volume (ml) 16.40 6 0.29 23 6 1.46 <0.01
Ejection fraction (%) 74.37 6 0.99 85.37 6 2.03 <0.01
Fractional shortening (%) 56.8 6 4.2 66.9 6 1.8 0.04
Preload-adjusted maximal
power (mWatts/ml2)
129.9 6 0.3 217.7 6 20.4 <0.01
Tau (ms) 9.28 6 0.58 7.86 6 0.33 0.03
dP/dt (+) (mmHg/s) 5343 6 432 7782 6 401 <0.01
dP/dt (2) (mmHg/s) 25265 6 399 26328 6 400 <0.01
Cardiac arterial
volume density Vv (%)
0.57 6 0.02 0.87 6 0.06 0.01
Cardiac arterial
surface density Sv (%)
0.13 6 0.01 0.17 6 0.003 0.01
Cardiac fractal dimension 1.76 6 0.01 1.85 6 0.007 <0.01
Hindlimb vascular
density (% area)
20.33 6 2.03 35.70 6 5.00 0.02
Hindlimb fractal dimension 1.39 6 0.02 1.54 6 0.01 0.01systemic vascular resistance (SVR). While the phenome-
non of vascular pruning generally serves to elevate SVR,
the reduction in cardiac output in synectin2/2mice likely
offsets this occurrence.
Arteriogenesis Defects in Adult Synectin2/2 Mice
To study whether synectin gene disruption impairs adult
arteriogenesis, we employed a femoral artery ligation
model. Immediately after ligation, there was a more pro-
found reduction in the hindlimb perfusion in synectin2/2
compared to control mice (Figures 4C and 4D). This is
consistent with the reduction in the arterial density in
synectin2/2 mice. Furthermore, while controls demon-
strated nearly complete recovery of tissue perfusion
over the next 2 weeks, this process was severely im-
paired in synectin2/2 animals (Figures 4C and 4D).
Selective Arterial Endothelial Cell Defects
in Synectin2/2 Mice
Because disruption of synectin expression affected the
formation of arterial, but not venous, vasculature, we
studied arterial and venous endothelial cells from synec-
tin2/2 and control mice in cell culture. Quantitative PCR
assessment of arterial and venous markers after twoFigure 4. Functional Effects of Synectin Disruption in Mice
(A) Mean baseline P/V loop assessment of synectin2/2 (green) and wild-type (black) 8- to 10-week-old male mice under anesthesia. Note smaller
size of LV chambers in synectin2/2 mice as represented by significantly lower intraventricular end-diastolic and end-systolic volumes.
(B) P/V loop analysis of end-diastolic (EDPVR) and end-systolic (ESPVR) pressure volume relationships after aortic occlusion.
(C) Laser Doppler images of the time course of perfusion in hindlimbs of synectin2/2 and wild-type mice.
(D) Quantitative analysis of laser Doppler images indicates significant alterations in hindlimb reperfusion immediate post and 14 days after fem-
oral artery ligation in synectin2/2 (black bars) mice. Means 6 SEM, p < 0.05.
Regulation of Arterial Branching Morphogenesis
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(A) Western blot of synectin expression in primary venous (vena cava) and arterial (aorta) endothelial cells from synectin2/2 and synectin+/+ mice.
Note equal gene expression in both cell types.
(B) Migration analysis of mouse arterial endothelial cells. Primary aortic endothelial cells from synectin+/+ (blue bars) and synectin2/2 (yellow
bars) mice were subjected to stimulation with FGF2, VEGF-A165, PDGF-BB, or EGF for 6 hr. Note significant decreased migration of synec-
tin2/2 compared to synectin+/+ cells in response to FGF2, VEGF, and PDGF, but not EGF. Means 6 SEM, p% 0.05.
(C) Migration analysis of mouse venous endothelial cells. Primary vena cava endothelial cells from synectin+/+ (blue bars) and synectin2/2 (yellow
bars) mice were subjected to stimulation with FGF2, VEGF-A165, PDGF-BB, or EGF for 6 hr. Note similar extent of migration demonstrated by
synectin2/2 compared to synectin+/+ cells under all conditions. Means 6 SEM, p% 0.05.
(D) Effect of restoration of synectin expression on endothelial cell migration. Mouse primary cardiac endothelial cells (MCEC) were isolated from
hearts of synectin2/2 and wild-type mice. MCEC from synectin2/2 (blue bars) and wild-type mice (yellow bars) as well synectin2/2 MCEC trans-
duced with adenoviral encoded synectin (Ad-Syn; red bars) or Ad-GFP (cyan bars) were subjected to stimulation with FGF2, VEGF-A165, PDGF-
BB, or EGF for 6 hr. Note decreased migration of synectin2/2 cells in response to FGF2, VEGF, and PDGF, but not EGF, that is restored by syn-
ectin transduction. Means 6 SEM, p% 0.05.
(E) Assessment of relative arterial endothelial cell migration rate. Primary aortic endothelial cells from synectin+/+ (blue bars) and synectin2/2
(yellow bars) mice were subjected to stimulation with 20% FBS, FGF2, or VEGF-A165 for 10 hr and migration rate was evaluated using time-lapse
imaging relative to stimulation with 0.5% FBS. Means 6 SEM, p% 0.05.
(F) Evaluation of relative venous endothelial cell migration rate. Primary vena cava endothelial cells from synectin+/+ (blue bars) and synectin2/2
(yellow bars) mice were subjected to stimulation with 20% FBS, FGF2, or VEGF-A165 for 10 hr and migration rate was evaluated using time-lapse
imaging relative to stimulation with 0.5% FBS. Means 6 SEM, p% 0.05.in vitro passages demonstrated that arterial cells had
a 2.63-fold higher ephrin B2 expression compared to ve-
nous cells, while the latter had a 3.66-fold higher EphB4
expression compared to arterial cells.
Synectin was equally expressed in both vena cava
and aortic endothelial cells in wild-type mice and no ex-
pression was detected in either cell type in synectin2/2
mice (Figure 5A). A number of angiogenic growth factors
have been implicated in regulation of branching mor-
phogenesis in general (Ferrara et al., 2003; Simons and
Ware, 2003) and arterial branching in particular (Carme-
liet, 2000; Fernandez et al., 2000; Parsons-Wingerter
et al., 2000). To test whether functional effects of these
growth factors were altered in endothelial cells from
synectin2/2 mice, we tested migration of these cells
in vitro. Primary synectin2/2 arterial endothelial cells mi-
grated markedly slower than synectin+/+ arterial cellsin response to FGF2, VEGF-A165, and PDGF-BB, but
demonstrated enhanced migration in response to EGF,
indicating that the absence of synectin did not indis-
criminately abort all signaling but rather affected distinct
signaling pathways (Figure 5B). At the same time, pri-
mary vena cava synectin2/2 endothelial cells showed
the same ability to migrate in cell culture as synectin+/+
vena cava endothelial cells (Figure 5C). The arterial-spe-
cific defect was not attributable to a difference in ex-
pression levels of the VEGF, PDGF, or FGF-2 receptors
between arterial and venous synectin+/+ endothelial
cells (data not shown).
Because the primary differences in arterial morpho-
genesis in synectin2/2mice were observed at the micro-
circulation level (<100 mm vessels), we also studied mi-
crovascular synectin2/2 and synectin+/+ endothelial
cells in vitro. Similar to the aortic endothelial cell data,
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(A) Proliferation analysis of mouse arterial endothelial cells. Primary aortic endothelial cells from synectin+/+ (blue bars) and synectin2/2 (yellow
bars) mice were subjected to stimulation with FGF2, VEGF-A165, PDGF-BB, or EGF for 48 hr and assessed relative to day 0. Note significant
decreased proliferation of synectin2/2 compared to synectin+/+ cells in response to FGF2, VEGF, and PDGF, but not EGF.
(B) Proliferation analysis of mouse venous endothelial cells. Primary vena cava endothelial cells from synectin+/+ (blue bars) and synectin2/2 (yel-
low bars) mice were subjected to stimulation with FGF2, VEGF-A165, PDGF-BB, or EGF for 48 hr and evaluated relative to day 0. Note similar
extent of proliferation demonstrated by synectin2/2 compared to synectin+/+ cells under all conditions.
(C) Effect of restoration of synectin expression on MCEC proliferation. MCEC from synectin2/2 (blue bars) and wild-type mice (yellow bars) as
well as synectin2/2MCEC transduced with adenoviral encoded synectin (Ad-Syn; red bars) or Ad-GFP (cyan bars) were subjected to stimulation
with FGF2, VEGF-A165, PDGF-BB, or EGF for 6 hr. Note decreased proliferation of synectin
2/2 cells in response to FGF2, VEGF, and PDGF, but
not EGF, that is restored by synectin transduction.
(D) Synectin expression and in vitro branching morphogenesis. MCEC derived from synectin2/2 and wild-type mice as well as adenoviral trans-
duced cells were plated in a 3D collagen gel supplemented with FGF2, VEGF-A165, or PDGF and branching formation was analyzed at indicated
time points. Note a significant decrease in branches/extension of vascular tube formations in synectin2/2 mice-derived endothelial cells com-
pared to wild-type controls. Color coded the same as above. *p < 0.01.
Error bars represent means 6 SEM, p% 0.05.microvascular cardiac synectin2/2 endothelial cells
demonstrated markedly impaired migration in response
to FGF2, VEGF-A165, or PDGF-BB while exhibiting an en-
hanced response to EGF (Figure 5D). Restoration of syn-
ectin expression in these cells fully restored responses
to the first three growth factors and diminished EGF re-
sponsiveness to control levels (Figure 5D).
To further test the effect of synectin disruption on cell
movement, we measured migration velocities of primary
synectin+/+ and synectin2/2 aortic and venous endothe-
lial cells. Similar to the wounding migration assay re-
sults, arterial, but not venous, synectin2/2 endothelial
cells demonstrated significantly reduced velocities in re-
sponse to 20% serum, FGF2, and VEGF (Figures 5E and
5F).
In vitro cell proliferation assay demonstrated that syn-
ectin2/2 arterial, but not venous, endothelial cells have
reduced proliferation rates in response to FGF2,
PDGF-BB, and VEGF-A165 and increased proliferationin response to EGF (Figures 6A and 6B) that were cor-
rected by re-expression of synectin (Figure 6C). These
findings mirror migration abnormalities seen in synec-
tin2/2 arterial endothelial cells.
The ability to form branches is an important character-
istic of endothelial cells. We tested the branching capac-
ity of synectin2/2 and synectin+/+ microvascular endo-
thelial cells in an in vitro 3D collagen assay. As in the
case of migration and proliferation assays, synectin2/2
cells had decreased ability to form branches in response
to FGF2, VEGF, and PDGF. Re-expression of synectin
fully restored the normal phenotype (Figure 6D).
Rac1 Translocation Defect in Synectin2/2 Arterial
Endothelial Cells
Cell migration requires cell polarization and lamellipodia
formation that involve activation of Rac1. All four tested
growth factors were equally effective activating Rac1
in both synectin2/2 and control endothelial cells
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791Figure 7. Effect of Synectin Deletion on Signaling and Cell Polarization
(A) Rac1 activation. GST pull-down of active Rac1 following growth factor stimulation of synectin2/2 and control endothelial cells. Note the ap-
pearance of activated Rac1 in both cell populations following growth factor stimulation.
(B) Quantitative analysis of lamellipodia formation. The maximal area occupied by lamellipodia was calculated as outlined in Experimental Pro-
cedures. Note a marked decrease in the extent of lamellipodia formation in synectin2/2 cells (blue bars) compared to synectin+/+ cells (yellow
bars) following FGF2, VEGF, and PDGF, but not EGF, stimulation. Means 6 SEM, p% 0.05.
(C) Lamellipodia formation images. Representative microphotographs of lamellipodia formation in synectin2/2 and synectin+/+ primary aortic
and vena cava endothelial cells before and after 1 hr of FGF2 induction. Note abnormal lamellipodia formation in synectin2/2 arterial endothelial
cells.
(D) FRET analysis of activated Rac1 localization to the leading edge. Localization of activated Rac1 (red) to the leading edge in synectin2/2 and
synectin+/+ primary aortic and vena cava endothelial cells before and after 15 min of FGF2 induction. Note absence of Rac1 localization to the
leading edge in synectin2/2 arterial endothelial cells.(Figure 7A). However, cell polarization and lamellipodia
formation in synectin2/2 microvascular endothelial cells
were markedly diminished in response to FGF2, VEGF-
A165, and PDGF-BB, but not to EGF, compared to endo-
thelial cells from control mice (Figures 7B and 7C), sug-
gesting that activated Rac1 was not properly localized
to distinct regions of the plasma cell membrane.
To further address this issue, arterial and venous
synectin2/2 and synectin+/+ endothelial cells were tran-
siently transfected with a YFP (yellow fluorescent
protein)-CRIB (cdc42/Rac1-interactive binding domain)-
CFP (cyan fluorescent protein) FRET (fluorescence
resonance energy transfer) construct (Kurokawa et al.,
2004) to monitor Rac1 activity and localization. After
FGF2 exposure, a prominent localizing FRET signal
was noted in synectin+/+, but not synectin2/2, arterial
endothelial cells (Figure 7D), while both synectin+/+
and synectin2/2 venous arterial cells displayed FRET
signal localization (Figure 7D). Similar observations
were made with VEGF and PDGF-BB stimulation (data
not shown). Thus, consistent with the observed defect
in lamellipodia formation, FRET analysis demonstrates
defective localization of the activated Rac1 in synec-
tin2/2 arterial, but not venous, endothelial cells.Discussion
Disruption of synectin gene expression in both zebrafish
and mice resulted in profound reduction in size and
complexity of the arterial network while, remarkably,
not affecting venous development. Adult animals with
homozygous deletion of the synectin gene also demon-
strated a profound arteriogenesis defect following liga-
tion of a major limb artery. At the cellular level, synec-
tin2/2 arterial, but not venous, endothelial cells
demonstrated marked impairment of motility, prolifera-
tion, and branching morphogenesis and the ability to
polarize in response to FGF2, VEGF-A165, and PDGF-
BB, but not EGF. Restoration of synectin expression
fully reverted these abnormalities to the control level.
These findings demonstrate that synectin is involved in
the regulation of the arterial, but not venous, vasculature
formation and branching morphogenesis both during
development and in adult life.
Homozygous deletion of synectin gene in mice results
in a generalized decrease in the size and complexity of
the arterial network and a reduction in body size, a
finding consistent with the observed reduction in endo-
thelial and smooth muscle cell mass. A change in the
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argues that not only the branching density but also the
pattern of branching is affected in synectin2/2 mice. In
addition to reduced branching, the entire arterial system
demonstrated an overall reduction in vessel caliber.
Similarly, synectin knockdown in zebrafish significantly
impaired arterial angioblast and endothelial cell migra-
tion and proliferation, overall affecting vessel branching
and enlargement, thereby phenocopying to a large ex-
tent the vascular defects in synectin-deficient mice.
Interestingly, the defective vessel development and
the branching defect are limited to the arterial system
without affecting vein formation. This was directly ob-
servable in both zebrafish and mouse models and is
consistent with the observation of reduced arterial, but
not venous, marker expressions. Although there are dis-
tinct molecular, functional, and morphological differ-
ences between arteries and veins, the mechanisms via
which these distinctions arise during vasculogenesis re-
main incompletely defined. Previous tracking studies in
zebrafish documented that distinct subsets of angio-
blasts give rise to either the arterial or venous lineage,
but not to both (Zhong et al., 2001). The impaired arterial
morphogenesis in synectinKD zebrafish embryos might
thus be attributable to a specific migration and/or prolif-
eration defect of such arterial angioblasts. However, our
results do not exclude the possibility that synectin may
also regulate arterial endothelial cell specification. If
true, synectin’s role in this process is likely to be of sec-
ondary relevance, as arteries still do form (albeit at re-
duced levels) in the absence of synectin.
The reduction in arterial branching would be expected
to result in tissue ischemia with concomitant abnormal-
ities in both cardiac function and systemic vascular re-
sistance. Consistent with this hypothesis, we observed
significant increases in HIF1a and VEGF-A165 mRNA
levels in the myocardium. At the functional level, there
was a significant worsening of heart function manifested
by alterations in both systolic and diastolic perfor-
mance. This is exactly the pattern of functional changes
typical of an ischemic ventricle. We did not observe in-
creased systemic vascular resistance in synectin2/2 an-
imals. Most likely the expected increase, due to the loss
of arterial branching, is masked by the significant im-
pairment of cardiac function in these mice.
The effect of synectin gene extinction on arteriogene-
sis was seen not only during development but in adult
mice as well, with synectin2/2 mice demonstrating
markedly reduced ability to regenerate the hindlimb ar-
terial tree following common femoral artery ligation,
with the defect once again limited to small caliber ar-
teries and arterioles.
We suggest that this arterial vascular defect is the re-
sult, in part, of impaired endothelial cell migration, an in-
tegral component of arteriogenic processes, in re-
sponse to growth factor stimulation that, in turn, is due
to the failure of endothelial cell polarization. All tested
growth factors activated Rac1 in both arterial and ve-
nous endothelial cells. Yet the ability to form lamellipo-
dia and migrate in response to VEGF-A165, FGF2, and
PDGF was impaired in arterial, but not venous, synec-
tin2/2 endothelial cells. This suggests that the defect
most likely involves synectin-dependent transport of ac-
tivated Rac1 to the leading edge. This was directly con-firmed by the FRET analysis of Rac1 activation that dem-
onstrated mistargeting of activated Rac1 in synectin2/2
arterial endothelial cells.
Remarkably, unlike the three other tested growth fac-
tors, EGF’s ability to stimulate cell migration is en-
hanced in synectin2/2 cells, demonstrating that synec-
tin does not indiscriminately affect every signaling
pathway but instead specifically regulates distinct sig-
naling pathways. The reason for the enhanced response
to EGF is unclear, but may be due to disregulation of
EGF signaling that is normally inhibited in the presence
of FGF stimulation (Schlessinger, 2004).
A most interesting aspect of this observation is the dif-
ference in the effect of synectin deletion on migration of
arterial versus venous endothelial cells. Both cell types
normally express the gene, yet the deletion affected mi-
gration only of arterial endothelium. This may suggest
that arterial endothelial cells express additional signals
necessary for synectin to function properly or that ex-
pression of these signaling molecules is suppressed in
venous endothelial cells. An intriguing outstanding
question is whether and to what extent the VEGF recep-
tor neuropilin-1, which is expressed at higher levels in
arteries than in veins (Herzog et al., 2001; Moyon et al.,
2001; Stalmans et al., 2002; Yuan et al., 2002), signals
via synectin. Interestingly, loss of neuropilin-1 in mice
causes predominantly arterial defects, without docu-
mented venous defects (Kawasaki et al., 1999), while
loss of the VEGF164 isoform (which binds neuropilin-1)
also causes arterial hypoplasia in the retina (Stalmans
et al., 2002). An additional possible candidate, interact-
ing with synectin and affecting preferentially arterial en-
dothelial cells, might be the NGF receptor TrkB (Dono-
van et al., 2000; Wagner et al., 2005). Obviously, other
partners interacting with synectin might play a role in ar-
terial endothelial cell morphogenesis.
Synectin is ubiquitously expressed in all tissues and
cell types (Zhang et al., 2004), but to date its biological
function has not been conclusively established. The ge-
netic defects reported in this study implicate synectin as
an important regulator of arterial development and
branching morphogenesis and suggest that its role in
vascular development and adult arteriogenesis may be
related to its involvement in regulation of arterial endo-
thelial cell polarization and migration in response to an-
giogenic growth factors.
Experimental Procedures
Generation of Synectin2/2 Mice
The synectin2/2mice were generated from embryonic stem (ES) cells
(129/SvEvBrd) from the Omnibank library (Lexicon Genetics) of gene-
trapped mouse ES cell clones infected with a retroviral gene trap vec-
tor VICTR25 which integrated into intron 1 of the synectin gene. ES
cells with the disrupted synectin gene were injected into C57BL/6J
blastocysts, which were then implanted in pseudopregnant female
mice. The resulting pups were crossed with C57BL/6J 3 129/SvJ
mice and the genotype of heterozygous animals was then deter-
mined by Southern blotting. The synectin2/2 mice were then gener-
ated by heterozygous crossing and then backcrossed nine times in-
cluding daughter-father crosses on C57BL/6 background. The tenth
generation of C57BL/6-backcrossed mice was used for all studies.
Primary Endothelial Cell Isolations
Primary endothelial cells from adult mouse hearts were isolated as
previously described (Li et al., 2002). Endothelial cells from both
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793the abdominal aorta and inferior vena cava were isolated in the same
manner.
Migration (Wound) Assay
Primary mouse aortic, vena cava, and cardiac endothelial cells were
plated in six-well cell culture plates coated with 10 mg/ml of fibronec-
tin in 20% fetal bovine serum-Dulbecco’s modified Eagle’s medium
(FBS-DMEM) and allowed to reach confluence. Cells were serum
starved for 24 hr in 0.5% FBS-DMEM and were then wounded with
a P20 pipette tip and stimulated with 20 ng/ml of FGF2, 10 ng/ml
VEGF-A165, 25 ng/ml PDGF-BB, or 20 ng/ml EGF in 0.5% FBS-
DMEM or 0.5% FBS-DMEM. The subsequent gaps were imaged at
baseline and 6 hr later. Migration distances were measured as pre-
viously described (Horowitz et al., 2002). All synectin rescue exper-
iments were performed 72 hr after primary cardiac endothelial cell
adenoviral transduction (MOI 50).
Migration Velocity Analysis
Primary endothelial cells were grown to confluence and then starved
for 24 hr in DMEM + 0.5% FBS. Individual cell velocity, following
stimulation with a growth factor, was measured using the ‘‘manual
tracking’’ plugin of the ImageJ program. Relative migration rates
were determined by normalizing the migration rate in any given con-
dition to the basal migration rate for that cell type.
Proliferation Assay
Primary mouse aortic, vena cava, and mouse primary cardiac endo-
thelial cells (MCEC) were plated in 96-well cell culture plates coated
with 10 mg/ml of fibronectin. Following 24 hr growth arrest in 0.5%
FBS-DMEM, CellTiter 96Aqueous One solution reagent (Promega)
was added according to the manufacturer’s recommendations to
TO wells and allowed to incubate for 2 hr at 37ºC. Wells were read
at 492 nm on a Labsystems Multiskan MCC/340 (Fisher Scientific)
ELISA plate reader. T2 wells were then stimulated with growth fac-
tors in the same concentration as above in 0.5% FBS-DMEM for
48 hr and read at 492 nm on the same ELISA plate reader. Data
are presented as T2:TO. Synectin rescue experiments were per-
formed as described above.
Three-Dimensional Collagen Matrix Assay
MCEC were plated onto the collagen layer and allowed to adhere for
2 hr at 37ºC. A second collagen layer was placed on top of the adher-
ent cells and allowed to gel for 1 hr at 37ºC. Cells were serum starved
for 24 hr in 0.5% FBS-DMEM and then stimulated with growth fac-
tors in the same concentration as above in 0.5% FBS-DMEM. Im-
ages were obtained with a Nikon inverted optical microscope at 0,
6, 12, 24, and 48 hr. Morphological capillary tube formations were
evaluated for structural networks, branch points, extension length,
and branches per extension.
Immunohistochemistry and Confocal Microscopy
Standard approaches were used. See Supplemental Experimental
Procedures in the Supplemental Data for details. Assessment of pri-
mary cardiac endothelial cell lamellipodia surface area was as-
sessed before and after growth factor stimulation with modification
as previously described (Prigozhina and Waterman-Storer, 2004).
Image acquisition was performed every 20 s via a 203 phase objec-
tive.
FRET Studies
For fluorescent resonance energy transfer (FRET) experiments,
a dual splitter from Optical Insights with Chroma filter set (505
dcxr, HQ 465/30m, HQ 560/55m) was used. Microscope excita-
tion and dichroic filter for CFP (Brightlight FF459) was from Sem-
rock. For FRET experiments, 603 oil immersion objective lenses
from Olympus were used. Ratio analysis was performed using
ImagePro software from Media Cybernetics. Cells were electro-
porated with the CFP-PAK-YFP construct (gift of M. Matsuda,
Osaka University, Japan), starved overnight in 0.5% FBS, stimu-
lated with FGF2 (50 ng/ml), and imaged 1 hr following stimula-
tion.
Synectin RT-PCR, Quantitative PCR, and Immunoblotting
Please see the Supplemental Data for details.Cardiac Pressure Volume Loop Analysis
A 1.4 F pressure volume catheter was introduced into the left ven-
tricle via the right carotid artery to determine P/V loop variables.
Animals were ventilated and anesthetized with 2% isoflurane,
and body temperature was maintained by standard methods.
Baseline parameters were recorded after 5 min under anesthesia
and compression of the aortic arch was induced to assess cardiac
function.
Surgical Hindlimb Ischemia Model and Microangiography
and Micro-CT
This was done as previously described (Tirziu et al., 2005). See the
Supplemental Data for details.
Laser Doppler Analysis
Hindlimb ischemia was induced as described above and perfusion
was assessed pre, immediately post, and 3, 7, and 14 days after sur-
gical intervention via the Moor LDI system with Moor LDI measure-
ment V3.09 software (Moor Instruments).
Zebrafish Analysis
Tg(fli1:EGFP)y1 zebrafish (Lawson and Weinstein, 2002) were main-
tained under standard laboratory conditions. The following mor-
pholino oligonucleotides were purchased from Gene Tools (LLC,
Corvallis): 50-CGTCCCAATCCAAGTGGCATTTTTG-30 (MO-ATG-1),
50-TTCTGCGTCCCAATCCAAGTGGCAT-30 (MO-ATG-2), both to
knock down synectin expression, and 50-CcTCCgAATCCAAGTcG
CtTTTTaG-30, a 5 base pair mismatch, as control (MO-ATG-ctr).
Different doses of morpholinos were injected into single- to four-
cell stage zebrafish embryos, using procedures as previously de-
scribed (Stalmans et al., 2002). All data shown in the manuscript
were obtained after injection of 16, 8, and 24 ng for MO-ATG-1,
MO-ATG-2, and MO-ctr, respectively. Between 30 and 60 injected
embryos were analyzed per experiment to identify alterations in
sprouting of intersegmental vessels of the trunk region, and each
experiment was repeated at least three times. The penetrance of
the phenotype was scored by counting the affected embryos. Con-
focal imaging of Tg(fli1:EGFP)y1 embryos was performed using
a Zeiss laser scanning microscope LSM510 and the 488 nm laser
emission was supplied by an argon laser. The efficacy of MO-
ATG-1 and MO-ATG-2 morpholinos was determined by immuno-
blot analysis of whole-embryo protein extracts (24 hpf embryos)
and a luciferase reporter assay (Ny et al., 2005). For rescue exper-
iments, full-length mouse synectin cDNA was transcribed with T7
RNA polymerase using the mMessage mMachine T7 in vitro tran-
scription kit (Ambion) according to the manufacturer’s instructions.
Rescue experiments were performed by injecting the MO-ATG-1
morpholino with and without 350 pg of mouse synectin mRNA,
as described.
Zebrafish BrdU Incorporation Assays
Dechorionated embryos were incubated in a solution containing 10
mM BrdU, 5% DMSO in embryo medium for 30 min at 6ºC–8ºC fol-
lowed by 60 min at 28ºC. After BrdU incorporation, embryos were al-
lowed to develop to the indicated stage (30 hpf) and fixed overnight
in 4% paraformaldehyde at 4ºC.
Zebrafish Whole-Mount In Situ Hybridization
and Immunostaining
Dechorionated embryos were fixed overnight in 4% paraformalde-
hyde at 4ºC. Whole-mount in situ hybridization was performed as
described (Stalmans et al., 2002), using antisense probes for z-syn-
ectin, z-cmlc2 (Yelon et al., 1999), z-ephrinB2a (Chan et al., 2001),
z-flt4 (Thompson et al., 1998), and z-myoD (Weinberg et al., 1996).
Embryos stained for z-synectin probe were embedded in paraffin
and sectioned at 7 mm. Tg(fli1:EGFP)y1 embryos were immuno-
stained with rabbit anti-GFP antibody (Torrey-Pines Biolabs) and
mouse anti-BrdU antibody (Santa Cruz Biotechnology), which
were then detected by using Alexa Fluor 488-conjugated anti-rabbit
and Alexa Fluor 518-conjugated anti-mouse secondary antibodies,
respectively. After immunostaining, the embryos were embedded
in paraffin and sectioned at 7–10 mm. Sections were mounted with
Vectashield DAPI (Vector Laboratories) and analyzed by using a
Zeiss Axio Imager microscope.
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See the Supplemental Data for details.
Supplemental Data
Supplemental Data include five figures, two tables, and Supplemen-
tal Experimental Procedures and are available at http://www.
developmentalcell.com/cgi/content/full/10/6/783/DC1/.
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